A Phase 1, Open-Label, Multicenter Study of Treatment with ACE1831, Comprised of Allogeneic Gamma Delta T Cells Conjugated to an Anti-CD-20 Antibody, in Patients (Pts) with B-Cell Relapsed/Refractory Non-Hodgkin's Lymphoma (R/R NHL) Meeting Abstract

cited authors

  • Stevens, Don A.; Romancik, Jason; Patel, Rushang D.; Nair, Ranjit; Pan, Janet; Chien, Stephanie; Olorunyomi, Ifeoluwapo; Tang, Sai-Wen; Kelley, Heather; Liu, Jerry; Kurman, Michael

Publication Date

  • November 5, 2024

webpage

published in

category

start page

  • 7251

end page

  • 7252

volume

  • 144